Antihypertensive Drugs Decrease Risk of Alzheimer Disease: Ginkgo Evaluation of Memory Study

Neurology - United States
doi 10.1212/wnl.0b013e3182a35228
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Blood Biomarkers for Memory: Toward Early Detection of Risk for Alzheimer Disease, Pharmacogenomics, and Repurposed Drugs

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2019English

Statins, Risk of Dementia, and Cognitive Function: Secondary Analysis of the Ginkgo Evaluation of Memory Study

Journal of Stroke and Cerebrovascular Diseases
SurgeryNeurologyCardiovascular MedicineRehabilitationCardiology
2012English

Pharmacogenomics of Antihypertensive Drugs: Rationale and Design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) Study

American Heart Journal
Cardiovascular MedicineCardiology
2009English

Risk Profiles of Alzheimer Disease

Canadian Journal of Neurological Sciences
MedicineNeurology
2011English

Erratum To: Ginkgo Biloba in Alzheimer"s Disease: A Systematic Review

Wiener Medizinische Wochenschrift
Medicine
2011English

Basic Research for Alzheimer′s Disease Drugs

Folia Pharmacologica Japonica
Pharmacology
2007English

Potential of Antihypertensive Drugs for Preventing and Treating Alzheimer’s Disease

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2008English

Antihypertensive Drugs Today

1979English

The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly

Archives of Internal Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy